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Parasite sequestration in childhood malaria 221Conclusion: Extensive sequestration is not a uniform requirement for severe paediatric ma-
laria. The pathophysiology of hyperlactataemia and prostration appears to be unrelated to
sequestered parasite biomass. Different mechanisms may underlie different severe malaria
syndromes, and different therapeutic strategies may be required to improve survival.
Published by Elsevier Ltd on behalf of The British Infection Association.Introduction
Malaria causes around 1 million deaths per year globally.1
Clinical features identify those at highest risk of death,2,3
but even with appropriate antimalarial therapy, mortality
rates remain at least 10e15%, and most deaths occur within
24e48 h of admission.4,5 The pathophysiology of severe ma-
laria is poorly understood, and hence the most appropriate
supportive care strategies are largely unknown,6e9 and
effective adjunctive treatments are lacking.10 Better un-
derstanding of the pathophysiology of severe malaria might
direct better use of simple supportive treatments and
reduce the huge burden of death.11
Most deaths from malaria occur in African children.1
Paediatric severe malaria (SM) comprises several different,
sometimes overlapping, syndromes e cerebral malaria
(CM), severe anaemia (SA), hyperlactataemia (LA) (or a
similar syndrome defined by acidosis or respiratory
distress11,12) and severe prostration (SP).13 CM and LA
are common and associated with high risk of death.2,14e16
The factors that determine why a child develops one
rather than another SM syndrome are unknown. Parasit-
ized red blood cells (pRBC) containing mature forms of
Plasmodium falciparum adhere to vascular endothelium,
a phenomenon known as sequestration,17 and can cause
microvascular obstruction, proposed to be central to the
pathogenesis of SM.11,18,19 Numerous sequestered pRBCs
are found in the cerebral microvasculature of children
and adults dying from CM,20,21 and correlate with retinal
microvascular pathology prior to death.21 However, there
are no contemporary postmortem studies in severe non-
CM syndromes in children, and interpretation of data
from postmortem studies is constrained by the absence
of control groups with uncomplicated malaria (UM) (who,
by definition, survive). Dondorp et al. estimated
sequestered-parasite biomass from the plasma concentra-
tion of P. falciparum histidine rich protein 2 (PfHRP2).22
Thai adults with SM had 10-fold higher sequestered-
parasite biomass than those with UM,22 but the association
of sequestration with discrete SM syndromes was not
examined. Other observations suggest mechanisms inde-
pendent of pRBC sequestration may also contribute to
SM: Plasmodium vivax can cause SM but exhibits little
cyto-adherence23,24; even in fatal P. falciparum CM the
degree of sequestration in cerebral vessels and tissues is
extremely variable21,25; and soluble mediators can also
cause endothelial dysfunction and microcirculatory
impairment in SM.11,26 Surprisingly, pRBC sequestration
has never been compared between children with SM and
UM controls, despite differences in SM manifestations be-
tween children and adults.13,27 In the present study we
aimed to quantify sequestered-parasite biomass in chil-
dren with UM and SM.Methods
Recruitment
With approval from the Gambia Government/MRC Labora-
tories Joint Ethics Committee, and the Ethics Committee of
the London School of Hygiene and Tropical Medicine, all
samples were collected with informed consent from the
child’s parent or guardian and used for an unmatched case-
control study nested within a larger prospective cohort, of
which methodological details have been published.28 During
each malaria season from August 2007 through January
2011, all Gambian children (<16 years old) presenting to
any of three health centres with P. falciparum malaria
(defined by clinical symptoms and 5000 asexual para-
sites/mL blood) were eligible for recruitment. Clinical man-
agement followed Gambian government guidelines, with SM
cases admitted to hospital. Blood cultures were not
routinely performed, but children were excluded if the
attending clinician suspected concomitant bacterial infec-
tion. SM was defined using modified WHO criteria13: SA, he-
moglobin <5 g/dL; LA, blood lactate >5 mmol/L; CM,
Blantyre coma score 2 for at least 2 h in the absence of hy-
poglycemia; SP, inability to sit unsupported (children >6
months of age) or inability to suck (children  6 month).
Children fulfilling criteria for both SP and SA, LA, or CM
were classified as having SA, LA, or CM rather than SP.
Eligible children without signs of SM were classified as UM.
On presentation, capillary blood was used to measure
lactate and glucose and to prepare thick and thin blood
films; venous blood was collected for sickle cell screen,
full blood count, and plasma storage (transported to the lab-
oratory on ice within 2 h, separated and stored at 70 C).
Outcome was assessed by survival 7 days after presentation.PfHRP2 ELISA and parasite biomass calculation
PfHRP2 was measured in duplicate in plasma by ELISA kit
(Cellabs) following the manufacturer’s instructions with
addition of a standard curve. Laboratory personnel were
unaware of the clinical status of subjects. Circulating-, total-
(PfHRP2-derived), and sequestered-parasite biomass esti-
mates were calculated using formulas derived by Dondorp
et al.22 with an initial parasite replication rate of 7.5 (the
average estimated in African children with SM),29 an elimina-
tion constant of 1.26,30 and modification of the blood volume
term in the equation to improve accuracy for children as fol-
lows: males, blood volume (mL) Z 312 þ (63.11  body
weight (kg)); females, blood volume (mL) Z 358 þ (62.34
 body weight (kg)).31 To account for variation in size of chil-
dren, parasite biomass was expressed as parasites/kg body
weight. Positive and negative values for sequestered biomass
222 A.J. Cunnington et al.occur because the model assumes sampling in mid-erythro-
cytic cycle such that total biomass may be over- or underes-
timated in an individual depending on the maturation stage
of parasites in their body22: in the absence of sequestration,
sequestered biomass estimates would form a symmetric dis-
tribution around zero.
Clonality of infection
Clonality of P. falciparum infection was assessed as
described previously.32
Bacterial co-infection
Bacteraemia with metabolically active Streptococcus pneu-
moniae and non-Typhoid Salmonella (NTS) was determined
using quantitative PCR on cDNA.33
Statistical analyses
Statistical analyses were performed using PASW statistics 18
(SPSS Inc.), GraphPad Prism (GraphPad Software Inc.) and the
R-statistical software (R Foundation). Data was log10 trans-
formed for parametric analyses to achieve normality, except
sequestered biomass (comprising positive and negative
values) which was analyzed with non-parametric methods.
Unpaired t-tests and likelihood-ratio tests were used to
compare means and medians, respectively, of groups. Con-
founding by age, prior antimalarial treatment and clonality
of infection was assessed by quantile regression (“quantreg”Figure 1 Flow diagram showing selectipackage, R-statistical software): a model including only
intercept was compared by means of likelihood-ratio tests
to models with any combination of the above covariates or
interaction terms. Correlationwasassessed using Spearman’s
rank correlation coefficient. To allow for the multiplicity of
tests resulting frommultiple responses andmultiple compar-
isons within a response, a false discovery rate (FDR) of 5%was
assumed, using the Benjamini and Hochberg approach.34 Po-
wer of likelihood-ratio tests for detecting an X-fold differ-
ence in medians was determined by bootstrapping (10,000
replicates): re-sampled data from the distribution of
sequestered-parasite biomass estimates was compared with
a similar sample to which (X  1) times the median seques-
tered biomass was added. Sensitivity analyses assessed the
range within which each model parameter could be varied
without rejection of the null hypothesis of equal median
sequestered biomass among groups. In addition, the effect
of joint variation in the parameters was assessed by sampling
10,000 candidate values from uniform distributions within
the limits defined for each individual parameter, determining
the frequency with which the likelihood-ratio test did not
reject the null hypothesis. The effect of parameter variation
on the Spearman’s rank correlation between lactate and
sequestered biomass was assessed identically.
Results
Complete clinical and laboratory data (Fig. 1) were avail-
able from 296 children (Tables 1 and 2), 127 (42.9%) with
SM, of whom 5 died (Fig. 2).on of subjects included in the study.
Table 1 Characteristics of children enrolled in the study.
Uncomplicated malaria Severe malaria
n % n %
All children 169 57.1 127 42.9
Sex
Male 93 55.0 76 59.8
Female 76 45.0 51 40.2
Ethnicity
Mandingo 64 37.9 53 41.7
Wollof 19 11.2 9 7.1
Fulla 34 20.1 24 18.9
Jola 31 18.3 19 15.0
Serehuli 1 0.6 1 0.8
Serere 6 3.6 4 3.1
Manjago 7 4.1 6 4.7
Aku 1 0.6 0 0
Other 4 2.4 6 4.7
Unknown 2 1.2 5 3.9
Prior antimalarial
Yes 24 14.2 29 22.8
No 136 80.5 92 72.4
Unknown 9 5.3 6 4.7
Clonality of infection
Monoclonal 48 28.4 28 22.0
Polyclonal 67 39.6 49 38.6
Not tested 54 32.0 50 39.4
Survival to day 7
Yes 169 100 122 96.1
No 0 0 5 3.93
Parasite sequestration in childhood malaria 223Children with SM were younger, more anaemic and throm-
bocytopaenic, and had higher blood lactate, parasitaemia,
parasite density, plasma PfHRP2 concentrations, circulating
parasite biomass, and total parasite biomass (calculated from
PfHRP2 concentration) than children with UM (Table 2 and
Fig. 3A). Sequestered-parasite biomass estimates for individ-
ual subjects included both positive and negative values
(Fig. 3B), which are possible because themodel for total para-
site biomass assumes that blood is sampled at a random time
point of the erythrocytic cycle of parasite development,22
but in reality subjectsmightpresentatany timefromjustafter
schizogony (when peripheral parasitaemia will be highest) to
just before schizogony when peripheral parasitaemia will be
lowest. However, comparison of median sequestered-
parasite biomass estimates between groups is less affected
by the imprecision of estimates for individuals, and seques-
tered biomass estimates were not significantly different be-
tween children with UM and SM (Table 2 and Fig. 3B). This
surprising finding prompted us to explore sequestered biomass
in subgroups of patientswith SM. A large proportion (56 of 127,
44.1%) of SM cases had SP alone, which is associated with a
lower risk of in-hospital mortality than the other indicators
of severity,2 so we reanalyzed the data for subjects with SM
excluding those with SP. The median sequestered-parasite
biomass in the71childrenwith themost severemanifestations
ofmalaria (i.e. CM, SA, LA or any combination of these, collec-
tively termed severe non-prostrated (SNP)) remained not
significantly different to that of the UM cases (Table 2,
Fig. 3B). To explore whether sequestered biomass was associ-
ated with any of the overlapping manifestations of SM, we
compared the median sequestered-parasite biomass in chil-
dren with UM with that in children with each inclusively
defined SM syndrome (Table 2). Sequestered biomass in chil-
dren with LA, the largest subgroup (nZ 64), was not signifi-
cantly different to those with UM. In contrast children with
CM, SA, and non-survivors, had very high-sequestered
biomass, but these subgroups were relatively small, and only
in SA cases was the median sequestered biomass significantly
higher than that in UM (Table 2, Fig. 3B). We also compared
sequestered biomass in exclusively defined SMmanifestations
with that in children with UM, but the small sizes of the sub-
groups only allowed us to confirm that median sequestered
biomass was similar in UM and LA (Table 2, Fig. 3B). Reanalysis
using a less stringent definition of LA (>4 mmol/L, as used by
Dondorp et al.22), increased the numbers of children classified
as having SM, SNP, and LA to 142, 103 and 100 respectively, but
did not change the significance of the comparisons between
the different categories (Table 3).
Blood lactate concentration is strongly associated with
mortality in P. falciparum malaria,14,15,22 but did not signif-
icantly correlate with sequestered-parasite biomass
(Spearman r Z 0.0315, P Z 0.59), whereas lactate corre-
lated equally well with circulating and total parasite
biomass estimates (Spearman r Z 0.50 (95% CI 0.40e0.58)
and 0.44 (95% CI 0.34e0.53) respectively, both P < 0.001).
There was no confounding effect of age, prior antima-
larial treatment or clonality of infection in the complete
data (PZ 0.95, PZ 0.11 and PZ 0.57 respectively): over-
all, the basic model explained the data best. Misclassifica-
tion bias, due to bacterial sepsis causing severe disease
manifestations in children with co-incidental parasitaemia,
was assessed by PCR to detect NTS or S. pneumoniaebacteraemia in 160 (54.1%) study subjects with suitable
samples (85 of 169 (50.3%) UM and 75 of 127 (59.1%) SM
cases); none (95% CI 0e2.3%) were positive. Additionally
no study subjects received intravenous antibiotics, making
significant misclassification unlikely. Sensitivity analysis re-
vealed that the model was highly robust to a realistic range
of variation in parameters (Table 4). The power to detect a
7-fold difference in median sequestered biomass between
subjects with UM and SM, UM and SNP, and UM and LA,
was 87%, 76%, and 72% respectively.Discussion
Improved understanding of the pathophysiology of SM may
allow a rational approach to improving supportive care, and
provide explanations for why so many interventions to date
have proved ineffective or even harmful.9,10 Unraveling the
pathophysiology of SM is difficult because studies in humans
can only describe associations, and cannot prove causality,
whilst the relevance of animal models of SM in humans is
contentious.35 Microcirculatory impairment is often thought
to be central to the pathogenesis of both CM and LA,11,18,19
Table 2 Comparison of indicators of severity and parasite biomass in uncomplicated and severe malaria.*
Clinical
manifestationa
n
(%)
Age
(years) GM
(95%CI)
Hemoglobin
(g/dL) GM
(95%CI)
Platelets
(109/L)b
GM (95%CI)
Lactate
(mmol/L) GM
(95%CI)
Parasitaemia
(%) GM
(95%CI)
Parasite
density
(105 /mL)
GM (95%CI)
Plasma
PfHRP2 (ng/mL)
GM (95%CI)
Circulating
parasite
biomass
(1010/kg)
GM (95%CI)
Total parasite
biomass (1010/
kg) GM (95%CI)
Sequestered
biomass
(1010/kg)c
median
(95%CI)
Uncomplicated 169 (57.1) 6.47
(5.88e7.12)
11.20
(10.90e11.51)
109.6
(98.7e121.7)
2.10
(1.97e2.24)
3.00
(2.52e3.58)
1.29
(1.08e1.53)
101.5
(84.43e122.1)
1.04
(0.87e1.24)
1.13
(0.93e1.37)
0.099
(0.10 to 0.37)
All severe 127 (42.9) 4.25
(3.89e4.64)
P< 0.001
9.11
(8.69e9.55)
P< 0.001
61.2
(52.7e71.2)
P< 0.001
4.69
(4.14e5.32)
P< 0.001
7.90
(6.49e9.61)
P< 0.001
2.79
(2.30e3.38)
P< 0.001
247.6
(202.1e303.3)
P< 0.001
2.38
(1.97e2.89)
P< 0.001
3.14
(2.54e3.89)
P< 0.001
0.12
(0.27 to 0.84)
P Z 0.89
Severe
SP 56 (18.9) 4.23
(3.71e4.82)
P< 0.001
9.66
(9.09e10.25)
P< 0.001
62.2
(50.8e76.2)
P< 0.001
2.88
(2.37e3.50)
P< 0.001
5.97
(4.34e8.21)
P< 0.001
2.25
(1.64e3.09)
P Z 0.002
191.3
(146.6e249.7)
P< 0.001
1.94
(1.41e2.66)
P< 0.001
2.39
(1.80e3.16)
P< 0.001
0.29
(0.71 to 0.57)
P Z 0.30
SNP 71 (24.0) 4.27
(3.77e4.83)
P< 0.001
8.70
(8.11e9.34)
P< 0.001
60.5
(48.5e75.6)
P< 0.001
6.90
(6.27e7.60)
P< 0.001
9.85
(7.70e12.6)
P< 0.001
3.31
(2.60e4.20)
P< 0.001
303.4
(225.2e408.8)
P< 0.001
2.81
(2.21e3.58)
P< 0.001
3.90
(2.85e5.33)
P< 0.001
0.57
(0.04 to 1.44)
P Z 0.20
Inclusive category
CM 16 (5.4) 3.99
(3.16e5.05)
P Z 0.003
8.60
(7.38e10.02)
P< 0.001
39.9
(20.5e77.9)
P< 0.001
7.31
(5.48e9.75)
P< 0.001
11.38
(7.44e17.4)
P< 0.001
3.60
(2.45e5.31)
P< 0.001
417.4
(211.8e822.7)
P< 0.001
3.10
(2.11e4.55)
P Z 0.001
5.52
(2.74e11.1)
P< 0.001
1.69
(0.49 to 8.45)
P Z 0.16
LA 64 (21.6) 4.38
(3.83e5.00)
P< 0.001
8.89
(8.30e9.52)
P< 0.001
58.1
(45.8e73.8)
P< 0.001
7.52
(6.95e8.13)
P< 0.001
10.33
(7.94e13.4)
P< 0.001
3.55
(2.75e4.59)
P< 0.001
312.4
(226.0e431.9)
P< 0.001
3.01
(2.32e3.91)
P< 0.001
3.98
(2.83e5.60)
P< 0.001
0.36
(0.19 to 1.30)
P Z 0.49
SA 6 (2.0) 2.75
(1.46e5.17)
P Z 0.001
4.54
(4.20e4.91)
P< 0.001
79.7
(43.5e146.1)
P Z 0.27
5.31
(2.25e12.49)
P< 0.001
10.17
(5.38e19.2)
P Z 0.01
1.87
(0.98e3.59)
P Z 0.43
484.8
(169.6e1386)
P Z 0.002
1.69
(0.92e3.12)
P Z 0.31
7.84
(2.82e21.8)
P< 0.001
4.64
(2.08e25.2)
P< 0.001
Exclusive category
CM 4 (1.4) 3.76
(2.15e6.57)
P Z 0.09
10.06
(7.19e14.09)
P Z 0.24
81.7
(21.9e304.6)
P Z 0.41
3.52
(2.33e5.31)
P Z 0.02
4.29
(1.01e18.3)
P Z 0.54
1.62
(0.46e5.69)
P Z 0.69
203.4
(38.0e1118)
P Z 0.26
1.39
(0.41e4.70)
P Z 0.62
2.53
(0.43e15.1)
P Z 0.21
1.69
(2.66 to 8.48)
LA 50 (16.9) 4.62
(3.99e5.35)
P< 0.001
9.32
(8.72e9.96)
P< 0.001
66.3
(52.6e83.6)
P< 0.001
7.12
(6.56e7.74)
P< 0.001
9.46
(6.83e13.1)
P< 0.001
3.43
(2.50e4.69)
P< 0.001
271.2
(187.2e392.7)
P< 0.001
2.88
(2.09e3.97)
P< 0.001
3.37
(2.28e4.97)
P< 0.001
0.07
(0.35 to 1.12)
P Z 0.99
SA 3 (1.0) 2.89
(1.41e5.89)
P Z 0.03
4.55
(3.61e5.74)
P< 0.001
96.3
(16.7e554.6)
P Z 0.75
2.76
(1.04e7.34)
P Z 0.26
10.73
(4.23e27.2)
P Z 0.06
1.85
(0.54e6.35)
P Z 0.59
277.1
(61.8e1242)
P Z 0.16
1.63
(0.49e5.37)
P Z 0.51
4.38
(1.03e18.6)
P Z 0.05
2.71
(1.44e5.23)
CMLA 11 (3.7) 3.94
(2.84e5.46)
P Z 0.01
8.63
(7.37e10.11)
P< 0.001
30.9
(12.3e77.7)
P< 0.001
8.82
(7.21e10.81)
P< 0.001
15.72
(11.7e21.2)
P< 0.001
4.96
(3.59e6.85)
P< 0.001
453.1
(199.8e1027)
P< 0.001
4.28
(3.13e5.87)
P< 0.001
6.06
(2.65e13.8)
P< 0.001
0.33
(0.55 to 11.5)
P Z 0.48
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Figure 2 Overlapping manifestations of severe malaria. Num-
ber of children (number of deaths, if any, in parentheses) with
each severemalaria syndrome. Syndromes were classified inclu-
sively (CM, cerebral malaria; LA, hyperlactataemia; SA, severe
anaemia) or exclusively (CM, LA, SA; CMLA, cerebral malaria
plus hyperlactataemia; CMSA, cerebral malaria plus severe
anaemia; LASA, hyperlactataemia plus severe anaemia;
CMLASA, cerebral malaria plus hyperlactataemia plus severe
anaemia).
Parasite sequestration in childhood malaria 225but it is not conclusively established whether extensive
pRBC sequestration is the primary cause of microcirculatory
impairment,36 or a consequence of inflammatory endothe-
lial activation and dysfunction which then facilitates
pRBC sludging and adherence.11,17,37 Furthermore, it is un-
certain whether different mechanisms underlie different
SM syndromes. The assumption that a single mechanism,
pRBC sequestration, causes all SM, led the authors of a
recent study to conclude that a “U-shaped” relationship be-
tween plasma PfHRP2 and mortality was due to many chil-
dren with low PfHRP2 concentrations dying from non-
malarial causes.30 Another explanation for this interesting
observation is that SM arises from heterogeneous mecha-
nisms, some related to high parasite burden, and some
occurring at lower total parasite burden.
The present study was undertaken to assess the role of
one of the most fundamental processes in P. falciparum
malaria, the sequestration of pRBCs, in causing severe dis-
ease. If SM is caused by extensive sequestration of pRBCs
within the microvasculature, then the sequestered biomass
would be expected to be higher in SM than in UM. We found
that all indices of parasite biomass (parasitaemia, parasite
density, PfHRP2 concentration, circulating parasite
biomass, and total parasite biomass) except the seques-
tered biomass were higher in SM compared with UM, sug-
gesting that extensive pRBC sequestration does not
uniformly underlie SM. This unexpected finding may be ex-
plained by the fact that the most frequent SM syndromes in
this study were LA and SP: children with these syndromes
had very similar median sequestered biomass to those
with UM and blood lactate concentrations correlated signif-
icantly with circulating biomass (and total biomass) but not
sequestered biomass. On the other hand, children with CM,
SA and fatal cases had high sequestered biomass; although
the small numbers of subjects in these groups in this study
Figure 3 Parasite biomass estimates in uncomplicated and
severe malaria. Median (horizontal line), interquartile range
(box), 10th and 90th centiles (whiskers). (A) Circulating and to-
tal parasite biomass estimates in uncomplicated (nZ 169) and
severe malaria (n Z 127). (B) Sequestered biomass estimates
for uncomplicated (UM) and different manifestations of severe
malaria (SM; SP, severe prostrated; SNP, severe non-
prostrated; CM, cerebral malaria; LA, hyperlactataemia; SA,
severe anaemia; CMLA, cerebral malaria plus hyperlactatae-
mia; CMSA, cerebral malaria plus severe anaemia; LASA, hyper-
lactataemia plus severe anaemia; CMLASA, cerebral malaria
plus hyperlactataemia plus severe anaemia).
226 A.J. Cunnington et al.preclude firm conclusions, our data are consistent with a
role for parasite sequestration in these syndromes. Howev-
er, the low sequestered biomass in children with LA, and
the lack of a significant correlation between sequestered
biomass and blood lactate concentrations, is a particularly
important observation because LA (or a large base deficit) is
one of the most frequent entities defining SM and risk of
death in African children with malaria.2,14e16
Our findings e that overall sequestered-parasite biomass
differed only 1.2-fold between SM and UM patients e
contrast with findings of an average 10-fold difference
between Thai adults with SM and UM in a similarly large
study.22 The proportions of SM cases with lactate levels
above 5 mmol/L were similar in the two studies (44% in
Thai adults and 50% in Gambian children), but the propor-
tions with CM differed greatly (64% and 13%, respectively),
and this difference may partially explain the discrepant
findings. Indeed, in our study the median sequestered
biomass in CM cases was 17-fold greater than in the UMcases. In Thai adults, blood lactate concentration corre-
lated significantly with sequestered-parasite biomass but
not circulating biomass,22 but this relationship may be
confounded by the large proportion of cases with CM; un-
fortunately the data provided in the Thai study does not
allow subgroup analysis by discrete SM syndromes.
In assessing the validity of our findings we must consider
methodological issues which might influence our results.
Plasma concentrations of PfHRP2 in our study were lower
than those reported in several other studies of SM,30,38e40
but the transmission setting appears to influence the
plasma PfHRP2 concentrations associated with SM,30 and
so absolute values should be compared with some caution.
In addition the proportions of children with CM, LA and SA
were very different to our study, with 29e57% of SM cases
in some of these studies having SA, compared with less
than 5% of SM cases in our population, and SA was strongly
associated with higher levels of PfHRP2.30,40 Our study was
conducted in children, whereas the model relating PfHRP2
concentration to parasite biomass was derived from data in
adults in a different transmission setting.22 To account for
differences between children and adults we modified rele-
vant model parameters, using data from studies in African
children,29,30 and we report parasite biomass data relative
to body weight. Based on the average replication rate esti-
mated in vivo in African children with SM,29 we used an
initial value for parasite replication rate of 7.5, whereas
in Thai adults Dondorp et al. used a value of 8,22 and in Af-
rican children Hendriksen et al. used a value of 3 (based on
in vitro and non-human primate data).30 Importantly, our
main findings were robust to variation of this parameter
over most of the range of replication rates estimated to
occur in African children with SM (as shown in Table 4).29
Furthermore, sequestered-parasite biomass in children
with CM in our study was quantitatively similar to that esti-
mated mathematically from parasite clearance curves in
Gambian children with CM.41 In a sensitivity analysis we
found that our main conclusions were robust to reasonable
variations in model parameters. However, we have made
the same assumptions as Dondorp et al., that model param-
eters are the same for UM and SM, and do not vary during
the course of infection.22 Although data from humans to
inform between-group and temporal variations in model pa-
rameters is lacking, recent data from Plasmodium berghei
ANKA infection in mice suggests that the sequestration
rate and the clearance rate of sequestered-parasites may
be dynamic throughout the course of an infection,42 making
this an important area for future study.
It is also important to consider potential sources of bias
in our study which might influence our results. Antibodies
against PfHRP2 might cause under-estimation of seques-
tered biomass in SM relative to UM cases, but young
Gambian children (who are most likely to have SM) are
the least likely to have antibodies to P. falciparum anti-
gens.43 Prior antimalarial treatment and polyclonal infec-
tions might cause deviation from the basic assumptions of
the model,22 but we found no evidence of any interaction
between age, prior antimalarial treatment, or clonality of
infection, with severity and sequestered-parasite burden.
Differences in parasite multiplication rate between UM
and SM cases might be a source of bias.22 However, parasite
multiplication rate is thought to be reduced at high parasite
Table 3 Comparison of indicators of severity and parasite biomass in uncomplicated and severe malaria when hyperla emia redefined as lactate >4 mmol/L.*
Clinical
manife-
stationa
n
(%)
Age
(years)
GM
(95%CI)
Hemoglobin
(g/dL)
GM (95%CI)
Platelets
(109/L)b
GM (95%CI)
Lactate
(mmol/L)
GM (95%CI)
Parasitaemia
(%)
GM (95%CI)
Parasite
density
(105 /mL)
GM (95%CI)
Plasma
PfHRP2
(ng/mL)
GM (95%C
Circulating
parasite
biomass
(1010/kg)
GM (95%CI)
Total
parasite
biomass
(1010/kg)
GM (95%CI)
Sequestered
biomass
(1010/kg)c
median
(95%CI)
Uncompli-
cated
154
(52.0)
6.68
(6.06e7.36)
11.34
(11.04e11.66)
110.6
(99.2e123.4)
1.95
(1.84e2.07)
2.88
(2.40e3.46)
1.23
(1.02e1.49)
99.1
(82.0e11 )
0.995
(0.83e1.20)
1.09
(0.90e1.33)
0.06
(0.16 to 0.35)
Severe 142
(48.0)
4.29
(3.93e4.69)
P< 0.001
9.19
(8.79e9.60)
P< 0.001
64.5
(56.0e74.4)
P< 0.001
4.66
(4.17e5.21)
P< 0.001
7.46
(6.18e9.01)
P< 0.001
2.69
(2.24e3.22)
P< 0.001
231.4
(189.4e2 8)
P< 0.0
2.29
(2.09e3.14)
P< 0.001
2.92
(2.37e3.60)
P< 0.001
0.22
(0.14 to 0.79)
P Z 0.71
SNP 103
(34.8)
4.23
(3.81e4.70)
P< 0.001
8.92
(8.46e9.40)
P< 0.001
67.8
(57.0e80.6)
P< 0.001
6.04
(5.59e6.52)
P< 0.001
8.45
(6.84e10.4)
P< 0.001
3.00
(2.45e3.66)
P< 0.001
254.3
(196.9e3 3)
P< 0.0
2.56
(2.09e3.14)
P< 0.001
3.26
(2.49e4.25)
P< 0.001
0.40
(0.09 to 0.92)
P Z 0.39
LA 100
(33.8)
4.28
(3.84e4.75)
P< 0.001
8.97
(8.52e9.43)
P< 0.001
65.7
(55.1e78.3)
P< 0.001
6.22
(5.79e6.68)
P< 0.001
8.66
(6.99e10.7)
P< 0.001
3.10
(2.53e3.80)
P< 0.001
262.5
(202.0e3 3)
P< 0.0
2.63
(2.15e3.26)
P< 0.001
3.36
(2.55e4.41)
P< 0.001
0.36
(0.09 to 1.01)
P Z 0.45
GM, geometric mean; 95% CI, 95% confidence interval
*P value for comparison with the uncomplicated malaria group using the unpaired t-test on log10-transformed data, when n  3, unl specified otherwise. Only tests with P  0.029 have a
false discovery rate of 5% or less using the Benjamini and Hochberg method to control for multiple comparisons and are conside significant (P value in bold type).
a Severe malaria cases were considered together, or in subgroups: SNP, severe non-prostrated, and LA, hyperlactataemia.
b Platelet count was not available for four subjects with prostration.
c P values for comparison with the uncomplicated malaria group using the likelihood-ratio test when n > 5.
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Table 4 Sensitivity analysis for variation in model parameters.
Range of variationa Robustness to
joint variationbMultiplication
rate, M
(/asexual cycle)
Elimination
constant, k
(/asexual cycle)
Rate of PfHRP2
secretion, R
(1015 pg/cycle)
Initial model
value
7.5 1.26 5.2
UM vs. SM 51e149% (3.8e11.2) 0e170% (0e2.14) 75e180% (3.9e9.36) 64%
UM vs. SNP 25e116% (1.88e8.7) 0e126% (0e1.59) 89e365% (4.63e18.98) 47%
UM vs. all LA 35e136% (2.6e10.2) 0e153% (0e1.93) 80e256% (4.16e13.31) 60%
Correlation
between lactate
and sequestered
biomassc
58e137% (4.34e10.3)
 r þ
18e155% (0.23e1.95)
 r þ
80e158% (3.71e8.22)
þ r 
63%
UM, uncomplicated malaria; SM, severe malaria; SNP, severe non-prostrated; LA, hyperlactataemia.
a Range of variation (absolute values) within which a likelihood-ratio test does not reject the null hypothesis that the median
sequestered-parasite biomass in the comparison groups is equal.
b Robustness (% of simulations in which the null hypothesis is not rejected) to joint variation of the parameters within their individually
determined ranges of variation.
c Using Spearmann’s rank correlation test, the sign of the correlation coefficient, r, is presented for the limits of the parameter range.
228 A.J. Cunnington et al.densities,44 which we observed predominantly in SM cases;
using the same multiplication rate for UM and SM is thus ex-
pected to lead to over- rather than under-estimation of the
total parasite biomass in children with SM. Other causes of
illness may mimic the clinical features of SM in children
with incidental parasitaemia and lead to misclassification.
One postmortem study showed that 23% of clinically
defined fatal cases of CM had an alternative cause of
death,21 but there are no comparable data for other SM syn-
dromes or for survivors of SM. By comparison our study was
conducted in a relatively low transmission setting43 (which
reduces the likelihood of incidental parasitaemia),45 used a
relatively high cut-off peripheral parasitaemia for inclusion
(which improves the specificity of diagnosis of malaria),45
and we found no evidence of bacterial co-infection, the
most likely alternative or confounding cause of severe
illness, using specific PCR for the two most common bacte-
rial pathogens.33 Two recent studies have reported rates of
bacteraemia in children with SM of around 5%40,46: one re-
ported lower rates of bacteraemia when parasitaemia
thresholds were applied to increase the specificity of the
diagnosis of SM; the other did not use a parasitaemia
threshold for inclusion, had a high proportion of children
with SA (an established risk factor for bacteraemia),47,48
and found the risk of bacteraemia was highest in children
with very low or very high PfHRP2 concentrations.40 We
did not assess the presence of malarial retinopathy, which
increases the specificity of the diagnosis of CM,21 however
CM subjects were a relatively small subgroup and amongst
those with highest sequestered biomass estimates. Finally,
the mortality rate in our study was only 3.9% in SM cases,
which might indicate that the children were ‘less’ seriously
ill than our SM definitions suggest, but is also consistent
with the lower risk of mortality in children,27 the propor-
tions of different SM syndromes in our study,2 exclusion of
children suspected to have non-malarial illness,28 and
with our subjects living relatively close to the health-care
facilities.28,49 After considering methodological issues and
these sources of bias we believe our findings are robust.How should our results be interpreted? Although the
number of children with SA was small, the association with
high PfHRP2 concentration is consistent with other
studies,30,40 and extensive sequestration could be a caus-
ative factor in SA. This would not necessarily require
sequestration in the microvasculature, since retention of
parasites in the slow open circulation of the spleen would
also remove pRBCs from the systemic circulation,50 and
could explain this observation. Furthermore, we speculate
that the role of microvascular obstruction by sequestered
pRBCs in SM pathophysiology may differ between the SM
syndromes of LA, CM, and SA, and possibly between chil-
dren and adults. Differences in the pathophysiology of
LA and CM are consistent with distinct patterns of risk
relative to exposure and age,51 additive effects on the
risk of mortality,16 and differences in the associated
pRBC adhesion phenotypes.52 LA in malaria is thought to
be due to microcirculatory impairment and consequent
tissue hypoxia.6,11 A recent study demonstrated impair-
ment of the ability of the microvasculature to increase tis-
sue oxygen delivery to match demand in severe malaria,
and the severity of this impairment correlated strongly
with blood lactate.53 Different host and parasite factors
may pre-dispose to sequestration-independent microcir-
culatory dysfunction in LA (perhaps mediated by inflam-
matory cytokines, hypoargininemia and nitric oxide
depletion),11,26 whereas pRBC sequestration may be
more important in CM. Both mechanisms may have syner-
gistic effects when LA and CM co-exist. A recent large
observational study in The Gambia showed that children
with LA who received a blood transfusion were much
less likely to die than those who did not, suggesting that
blood transfusion may be one way to improve tissue oxy-
gen delivery in this group.54 Surprisingly though, no ran-
domized trials have been performed to assess the
benefit of even this simple intervention.8 However, micro-
circulatory impairment is not the only pathophysiological
mechanism occurring in SM, and in common with many
other infections, an excessive inflammatory response is
Parasite sequestration in childhood malaria 229considered to contribute to severe disease.55 Since
PfHRP2 is mainly released at schizogony, its concentration
parallels the release of pro-inflammatory parasite mole-
cules such as glycosylphosphatidylinositol and hemozoin
from within the pRBC,56 and PfHRP2 concentration corre-
lates significantly with C-reactive protein in plasma.57 The
production of inflammatory cytokines such as TNF-a may
be directly involved in the pathophysiology of SM,37 and
the distribution of pRBCs in the spleen, systemic circula-
tion, or sequestered in specific vascular beds, could influ-
ence local concentrations of pro-inflammatory cytokines
in, e.g. the brain. Thus interpretation of differences in
parasite biomass estimates between SM groups must also
be considered alongside concomitant differences in the
magnitude and localization of inflammatory stimuli which
could influence the presentation of SM. Future studies of
malaria pathogenesis and adjunctive treatment should
carefully evaluate differences between SM syndromes,
and consider the possibility that they require different in-
terventions to improve survival.
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